Filing Details
- Accession Number:
- 0001225208-25-002922
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-04 19:52:14
- Reporting Period:
- 2025-02-28
- Filing Date:
- 2025-03-04
- Accepted Time:
- 2025-03-04 19:52:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1739940 | Cigna Group | CI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1318751 | David Cordani | 900 Cottage Grove Road Bloomfield CT 06002 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Acquisiton | 2025-02-28 | 49,437 | $0.00 | 170,783 | No | 4 | A | Direct | |
| Common Stock, $.01 Par Value | Acquisiton | 2025-02-28 | 11,117 | $0.00 | 181,900 | No | 4 | A | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2025-02-28 | 4,696 | $305.86 | 177,204 | No | 4 | F | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2025-02-28 | 22,910 | $305.86 | 154,294 | No | 4 | F | Direct | |
| Common Stock, $.01 Par Value | Disposition | 2025-03-03 | 26,527 | $308.12 | 127,767 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $.01 Par Value | Employee Stock Option (Right to Buy) | Acquisiton | 2025-02-28 | 39,476 | $0.00 | 39,476 | $305.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 39,476 | 2026-03-01 | 2035-02-28 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $.01 Par Value | 1,757 | Indirect | By 401(k) |
| Common Stock, $.01 Par Value | 334,387 | Indirect | By GRAT |
| Common Stock, $.01 Par Value | 153,801 | Indirect | By Trust |
Footnotes
- The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
- Reflects the transfer by the Reporting Person of 334,387 shares of common stock on May 8, 2024 to the Reporting Person's grantor retained annuity trust. In addition, it reflects the transfer by the Reporting Person's grantor retained annuity trust of 99,918 shares of common stock on January 27, 2025 in respect of a payment of an annual annuity to the Reporting Person pursuant to the terms of the grantor retained annuity trust.
- These restricted shares vest in three equal annual installments beginning March 1, 2026.
- Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
- Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2024.
- Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
- This option vests in three equal annual installments beginning March 1, 2026.
Billionaire Hedge Funds
